22 February 2013Cost – Effectiveness Analysis by Adding Rituximab in the Treatment of Diffuse Large B – Cell LymphomaABSTRACT Objectives: To determine cost-effectiveness of CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) compared with R-CHOP (CHOP plus Rituximab) in adult patients with diffuse large B-cell lymphoma, […]